Samsung Biologics Co.,Ltd.
207940
Rangering i aksjer
#496
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Aksjekurs
$1,028.49
Markedsverdi
$47.88B
Endring (1 dag)
-3.67%
Endring (1 år)
-18.37%
Land
KR
Handel Samsung Biologics Co.,Ltd. (207940)
Kategori
Healthcare
Inntekter for Samsung Biologics Co.,Ltd. (207940)
Inntekter i 2026 TTM: 0
Ifølge Samsung Biologics Co.,Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Samsung Biologics Co.,Ltd. fra 2014 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2025 | $1.47B | 55.69% |
| 2024 | $941.97M | 8.88% |
| 2023 | $865.17M | 8.20% |
| 2022 | $799.60M | 69.37% |
| 2021 | $472.11M | 92.69% |
| 2020 | $245.01M | 82.02% |
| 2019 | $134.61M | -50.53% |
| 2018 | $272.09M | -350.00% |
| 2017 | $-108.84M | -43.17% |
| 2016 | $-191.50M | -109.05% |
| 2015 | $2.12B | -2,423.97% |
| 2014 | $-91.10M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $5.27B | - |
US
|
|
| $-3.09B | - |
US
|
|
| $-4.02B | - |
AU
|
|
| $3.01B | - |
BE
|
|
| $1.95B | - |
NL
|
